# TEsting METformin Against Cognitive Decline in HD

> **NCT04826692** · PHASE3 · COMPLETED · sponsor: **Instituto de Investigacion Sanitaria La Fe** · enrollment: 60 (actual)

## Conditions studied

- Huntington Disease

## Interventions

- **DRUG:** Metformin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04826692
- **Lead sponsor:** Instituto de Investigacion Sanitaria La Fe
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-04-11
- **Primary completion:** 2025-06-10
- **Final completion:** 2025-06-10
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2025-09-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04826692

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04826692, "TEsting METformin Against Cognitive Decline in HD". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04826692. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*